Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease

被引：0
|
作者：
Trenschel, R
Trampenau, C
Ditschkowski, M
Elmaagacli, A
Ottinger, H
Steckel, N
Biersack, H
Peceny, R
Beelen, D
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [21] Plasma adiponectin levels in patients with infliximab treatment for steroid-refractory gastrointestinal acute graft-versus-host disease
    Murayama, Yoko
    Tsutsui, Shusaku
    Shinomura, Yasuhisa
    Hayashi, Norio
    GASTROENTEROLOGY, 2008, 134 (04) : A215 - A215
  • [22] Infliximab and Low Dose Alemtuzumab in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
    Kobrinski, Daniel
    Rodriguez, Tulio E.
    Smith, Scott E.
    Tsai, Stephanie B.
    Al-Mansour, Zeina
    Parthasarathy, Mala
    Stiff, Patrick J.
    BLOOD, 2016, 128 (22)
  • [23] Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease
    Yalniz, Fevzi E.
    Hefazi, Mehrdad
    McCullough, Kristen
    Litzow, Mark R.
    Hogan, William J.
    Wolf, Robert
    Alkhateeb, Hassan
    Kansagra, Ankit
    Damlaj, Moussab
    Patnaik, Mrinal M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1478 - 1484
  • [24] Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease
    Ilhan, O
    Arat, M
    Arslan, Ö
    Ayyildiz, E
    Sanli, H
    Beksac, M
    Özcan, M
    Gürman, G
    Akan, H
    TRANSFUSION AND APHERESIS SCIENCE, 2004, 30 (03) : 185 - 187
  • [25] Brentixumab vedotin for the treatment of steroid-refractory chronic graft-versus-host disease
    DeFilipp, Zachariah
    Li, Shuli
    Kempner, Maria
    Brown, Jami
    Del Rio, Candice
    Valles, Betsy
    Ballen, Karen
    Dey, Bimalangshu
    El-Jawahri, Areej
    McAfee, Steven
    Spitzer, Thomas
    Chen, Yi-Bin
    BONE MARROW TRANSPLANTATION, 2018, 53 : 398 - 398
  • [26] WEEKLY BORTEZOMIB FOR THE TREATMENT OF STEROID REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)
    Miller, A. M.
    Schneider, R.
    Agura, E. A.
    Vance, E.
    Bergman, R. B.
    Fay, J.
    Pineiro, L.
    Powell, S.
    Ovcina, Tadic M.
    Sampson, C. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S343 - S343
  • [27] Treatment of steroid-refractory acute graft-versus-host disease with ATG (Fresenius)
    Kamelander, J.
    Navratil, M.
    Koristek, Z.
    Doubek, M.
    Krejci, M.
    Brychtova, Y.
    Racil, Z.
    Mendelova, D.
    Weinreb, M.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S241 - S241
  • [28] Experience with extracorporeal photopheresis for treatment of acute steroid refractory graft-versus-host disease
    Fritsch, S.
    Herold, T.
    Teepe, C.
    Rank, A.
    Ledderose, G.
    Hausmann, A.
    Kolb, H. -J.
    Tischer, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S99 - S100
  • [29] Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease
    Benito, AI
    Furlong, T
    Martin, PJ
    Anasetti, C
    Appelbaum, FR
    Doney, K
    Nash, RA
    Papayannopoulou, T
    Storb, R
    Sullivan, KM
    Witherspoon, R
    Deeg, HJ
    TRANSPLANTATION, 2001, 72 (12) : 1924 - 1929
  • [30] Etanercept treatment for steroid refractory acute graft-versus-host disease (GVHD) of the intestine
    Detrait, M.
    Van denneste, E.
    Vekemans, M. C.
    Sone, A.
    Bosly, A.
    Lambert, C.
    Hermans, C.
    Ferrant, A.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 267 - 267
12345